Skip to content
Labcorp
-
Labcorp partners with Geneoscopy for nationwide commercial rollout of ColoSense
Developed by Geneoscopy and offered commercially through Labcorp, ColoSense is intended for adults aged 45 to 85 years who are considered to have an average risk of colorectal cancer.